| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 35.766 | 37.265 | 41.056 | 47.028 | 43.318 | 45.696 | 48.002 | 50.177 | 49.293 |
| Total Income - EUR | - | 35.766 | 37.265 | 41.056 | 47.028 | 43.318 | 45.696 | 48.002 | 50.177 | 49.293 |
| Total Expenses - EUR | - | 2.351 | 3.499 | 3.859 | 11.442 | 15.550 | 13.712 | 16.070 | 17.507 | 17.230 |
| Gross Profit/Loss - EUR | - | 33.416 | 33.766 | 37.197 | 35.586 | 27.768 | 31.984 | 31.932 | 32.670 | 32.064 |
| Net Profit/Loss - EUR | - | 32.343 | 32.648 | 35.965 | 34.175 | 26.579 | 30.773 | 31.113 | 32.273 | 30.762 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Tagema Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 25.067 | 21.477 | 20.642 | 16.630 | 13.116 | 9.526 | 7.161 |
| Current Assets | - | 32.859 | 33.806 | 17.233 | 16.463 | 21.975 | 16.355 | 36.398 | 33.676 | 28.545 |
| Inventories | - | 76 | 74 | 176 | 193 | 245 | 240 | 0 | 0 | 0 |
| Receivables | - | 22.873 | 23.007 | 7.823 | 4.021 | 3.034 | 4.765 | 28.648 | 30.004 | 24.928 |
| Cash | - | 9.910 | 10.725 | 9.234 | 12.249 | 18.696 | 11.350 | 7.750 | 3.671 | 3.617 |
| Shareholders Funds | - | 32.387 | 33.314 | 41.592 | 36.240 | 40.424 | 31.882 | 32.540 | 32.332 | 30.902 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 472 | 492 | 709 | 1.700 | 2.193 | 1.103 | 16.975 | 10.870 | 4.805 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tagema Medical S.r.l.